Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Source link
More Articles Like This
- Advertisement -
Thursday, November 6, 2025
Category
Links
Stay connected
Mail us : thetimes365@thetimes365.com
Newsletter Signup
- Advertisement -
© thetimes365 | All rights reserved.